Scientific article
Open access

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

Published inThe Journal of clinical investigation, vol. 110, no. 6, p. 851-860
Publication date2002

In type 2 diabetes, chronic hyperglycemia is suggested to be detrimental to pancreatic beta cells, causing impaired insulin secretion. IL-1beta is a proinflammatory cytokine acting during the autoimmune process of type 1 diabetes. IL-1beta inhibits beta cell function and promotes Fas-triggered apoptosis in part by activating the transcription factor NF-kappaB. Recently, we have shown that increased glucose concentrations also induce Fas expression and beta cell apoptosis in human islets. The aim of the present study was to test the hypothesis that IL-1beta may mediate the deleterious effects of high glucose on human beta cells. In vitro exposure of islets from nondiabetic organ donors to high glucose levels resulted in increased production and release of IL-1beta, followed by NF-kappaB activation, Fas upregulation, DNA fragmentation, and impaired beta cell function. The IL-1 receptor antagonist protected cultured human islets from these deleterious effects. beta cells themselves were identified as the islet cellular source of glucose-induced IL-1beta. In vivo, IL-1beta-producing beta cells were observed in pancreatic sections of type 2 diabetic patients but not in nondiabetic control subjects. Similarly, IL-1beta was induced in beta cells of the gerbil Psammomys obesus during development of diabetes. Treatment of the animals with phlorizin normalized plasma glucose and prevented beta cell expression of IL-1beta. These findings implicate an inflammatory process in the pathogenesis of glucotoxicity in type 2 diabetes and identify the IL-1beta/NF-kappaB pathway as a target to preserve beta cell mass and function in this condition.

  • Adult
  • Aged
  • Animals
  • Antioxidants/pharmacology
  • Cells, Cultured
  • Diabetes Mellitus, Type 2/metabolism
  • Female
  • Gerbillinae
  • Glucose/ metabolism/toxicity
  • Humans
  • Hyperglycemia/metabolism
  • Interleukin-1/genetics/ metabolism
  • Islets of Langerhans/drug effects/ metabolism
  • Male
  • Middle Aged
  • Nitric Oxide Synthase/genetics/metabolism
  • Nitric Oxide Synthase Type II
  • Proline/ analogs & derivatives/pharmacology
  • Receptors, Interleukin-1/metabolism
  • Thiocarbamates/pharmacology
Citation (ISO format)
MAEDLER, Kathrin et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. In: The Journal of clinical investigation, 2002, vol. 110, n° 6, p. 851–860. doi: 10.1172/JCI15318
Main files (1)
ISSN of the journal0021-9738

Technical informations

Creation07/12/2010 11:58:50 AM
First validation07/12/2010 11:58:50 AM
Update time03/14/2023 3:51:51 PM
Status update03/14/2023 3:51:50 PM
Last indexation02/12/2024 6:53:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack